Assessing anti-malarial drug effects ex vivo using the haemozoin detection assay

[1]  Rui Gardner,et al.  Light depolarization measurements in malaria: A new job for an old friend , 2015, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[2]  Jongyoon Han,et al.  Micromagnetic resonance relaxometry for rapid label-free malaria diagnosis , 2014, Nature Medicine.

[3]  D. Kwiatkowski,et al.  Spread of artemisinin resistance in Plasmodium falciparum malaria. , 2014, The New England journal of medicine.

[4]  C. Amaratunga,et al.  Flow Cytometry-Based Analysis of Artemisinin-Resistant Plasmodium falciparum in the Ring-Stage Survival Assay , 2014, Antimicrobial Agents and Chemotherapy.

[5]  Stephan Karl,et al.  Evaluation of a Novel Magneto-Optical Method for the Detection of Malaria Parasites , 2014, PloS one.

[6]  Dmitri O. Lapotko,et al.  Hemozoin-generated vapor nanobubbles for transdermal reagent- and needle-free detection of malaria , 2013, Proceedings of the National Academy of Sciences.

[7]  B. Genton,et al.  A molecular marker of artemisinin-resistant Plasmodium falciparum malaria , 2013, Nature.

[8]  Saorin Kim,et al.  Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies. , 2013, The Lancet. Infectious diseases.

[9]  S. Munga,et al.  Challenges to malaria control and success stories in Africa , 2013 .

[10]  D. V. van Schalkwyk,et al.  Culture-adapted Plasmodium falciparum isolates from UK travellers: in vitro drug sensitivity, clonality and drug resistance markers , 2013, Malaria Journal.

[11]  L. Rénia,et al.  Field-Based Flow Cytometry for Ex Vivo Characterization of Plasmodium vivax and P. falciparum Antimalarial Sensitivity , 2013, Antimicrobial Agents and Chemotherapy.

[12]  H. Shapiro,et al.  Cytometry in Malaria—A Practical Replacement for Microscopy? , 2013, Current protocols in cytometry.

[13]  P. Roepe,et al.  Quinoline drug-heme interactions and implications for antimalarial cytostatic versus cytocidal activities. , 2013, Journal of medicinal chemistry.

[14]  M. Mota,et al.  A Novel Flow Cytometric Hemozoin Detection Assay for Real-Time Sensitivity Testing of Plasmodium falciparum , 2013, PloS one.

[15]  H. Shapiro,et al.  Haemozoin detection in infected erythrocytes for Plasmodium falciparum malaria diagnosis-prospects and limitations. , 2012, Acta tropica.

[16]  Benjamin K. Wilson,et al.  Detection of malarial byproduct hemozoin utilizing its unique scattering properties. , 2011, Optics express.

[17]  B. Mordmüller,et al.  In vitro activity of new artemisinin derivatives against Plasmodium falciparum clinical isolates from Gabon. , 2011, International journal of antimicrobial agents.

[18]  D. Newman,et al.  Laboratory evaluation on the sensitivity and specificity of a novel and rapid detection method for malaria diagnosis based on magneto-optical technology (MOT) , 2010, Malaria Journal.

[19]  H. Vial,et al.  Reliability of Antimalarial Sensitivity Tests Depends on Drug Mechanisms of Action , 2010, Journal of Clinical Microbiology.

[20]  K. Silamut,et al.  Artemisinin resistance in Plasmodium falciparum malaria. , 2009, The New England journal of medicine.

[21]  A. Nzila,et al.  Chloroquine resistance before and after its withdrawal in Kenya , 2009, Malaria Journal.

[22]  T. Theander,et al.  Five-year surveillance of molecular markers of Plasmodium falciparum antimalarial drug resistance in Korogwe District, Tanzania: accumulation of the 581G mutation in the P. falciparum dihydropteroate synthase gene. , 2009, The American journal of tropical medicine and hygiene.

[23]  M. Fukuda,et al.  Evidence of artemisinin-resistant malaria in western Cambodia. , 2008, The New England journal of medicine.

[24]  B. Mordmüller,et al.  Comprehensive study of proteasome inhibitors against Plasmodium falciparum laboratory strains and field isolates from Gabon , 2008, Malaria Journal.

[25]  John J. Erickson,et al.  Monitoring Plasmodium falciparum growth and development by UV flow cytometry using an optimized Hoechst‐thiazole orange staining strategy , 2008, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[26]  D. Ménard,et al.  Performance and reliability of the SYBR Green I based assay for the routine monitoring of susceptibility of Plasmodium falciparum clinical isolates. , 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[27]  A. Dicko,et al.  Efficacy, safety, and selection of molecular markers of drug resistance by two ACTs in Mali. , 2008, The American journal of tropical medicine and hygiene.

[28]  J. Meynard,et al.  In Vitro Monitoring of Plasmodium falciparum Drug Resistance in French Guiana: a Synopsis of Continuous Assessment from 1994 to 2005 , 2007, Antimicrobial Agents and Chemotherapy.

[29]  Howard M Shapiro,et al.  Cytometry in malaria: Moving beyond Giemsa , 2007, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[30]  R. Tahar,et al.  Molecular epidemiology of malaria in Cameroon. XXVII. Clinical and parasitological response to sulfadoxine-pyrimethamine treatment and Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase alleles in Cameroonian children. , 2007, Acta tropica.

[31]  P. Ringwald,et al.  Comparison of a SYBR Green I-Based Assay with a Histidine-Rich Protein II Enzyme-Linked Immunosorbent Assay for In Vitro Antimalarial Drug Efficacy Testing and Application to Clinical Isolates , 2007, Antimicrobial Agents and Chemotherapy.

[32]  M. Fukuda,et al.  In Vitro Antimalarial Activity of Azithromycin, Artesunate, and Quinine in Combination and Correlation with Clinical Outcome , 2006, Antimicrobial Agents and Chemotherapy.

[33]  T. Taylor,et al.  Return of chloroquine antimalarial efficacy in Malawi. , 2006, The New England journal of medicine.

[34]  J. Baird,et al.  Production and validation of durable, high quality standardized malaria microscopy slides for teaching, testing and quality assurance during an era of declining diagnostic proficiency , 2006, Malaria Journal.

[35]  J. Le bras,et al.  Assessment of the Drug Susceptibility of Plasmodium falciparum Clinical Isolates from Africa by Using a Plasmodium Lactate Dehydrogenase Immunodetection Assay and an Inhibitory Maximum Effect Model for Precise Measurement of the 50-Percent Inhibitory Concentration , 2006, Antimicrobial Agents and Chemotherapy.

[36]  C. J. Woodrow,et al.  Antimalarial drugs: recent advances in molecular determinants of resistance and their clinical significance , 2006, Cellular and Molecular Life Sciences CMLS.

[37]  Harald Noedl,et al.  Simple Histidine-Rich Protein 2 Double-Site Sandwich Enzyme-Linked Immunosorbent Assay for Use in Malaria Drug Sensitivity Testing , 2005, Antimicrobial Agents and Chemotherapy.

[38]  W. Wernsdorfer,et al.  A histidine-rich protein 2-based malaria drug sensitivity assay for field use. , 2004, The American journal of tropical medicine and hygiene.

[39]  L. Basco.  Molecular epidemiology of malaria in cameroon. XX. Experimental studies on various factors of in vitro drug sensitivity assays using fresh isolates of Plasmodium falciparum. , 2004, The American journal of tropical medicine and hygiene.

[40]  J. Kublin,et al.  Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. , 2003, The Journal of infectious diseases.

[41]  C. Wongsrichanalai,et al.  Malaria drug-sensitivity testing: new assays, new perspectives. , 2003, Trends in parasitology.

[42]  P. Ringwald,et al.  In Vitro Activities of Piperaquine and Other 4-Aminoquinolines against Clinical Isolates of Plasmodium falciparum in Cameroon , 2003, Antimicrobial Agents and Chemotherapy.

[43]  W. Wernsdorfer,et al.  Reassessment of the resistance of Plasmodium falciparum to chloroquine in Gabon: implications for the validity of tests in vitro vs. in vivo. , 2002, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[44]  P. Kremsner,et al.  Comparison of methods for the rapid laboratory assessment of children with malaria. , 2001, The American journal of tropical medicine and hygiene.

[45]  S. Kano,et al.  Variation of incubation time in an in vitro drug susceptibility test of Plasmodium falciparum isolates studied in the Solomon Islands. , 2001, Parasitology international.

[46]  M. Duraisingh,et al.  Inoculum effect leads to overestimation of in vitro resistance for artemisinin derivatives and standard antimalarials: a Gambian field study , 1999, Parasitology.

[47]  I. Adagu,et al.  Plasmodium falciparum: in vitro chloroquine susceptibility and allele-specific PCR detection of Pfmdr1Asn86Tyr polymorphism in Lambarene, Gabon , 1998, Parasitology.

[48]  Warhurst Dc,et al.  Plasmodium falciparum : in vitro chloroquine susceptibility and allele-specific PCR detection of Pfmdr1 Asn86Tyr polymorphism in Lambarene, Gabon , 1998 .

[49]  J. Le bras,et al.  Plasmodium falciparum and Plasmodium vivax: lactate dehydrogenase activity and its application for in vitro drug susceptibility assay. , 1995, Experimental parasitology.

[50]  R. Reese,et al.  Protein and nucleic acid synthesis during synchronized growth of Plasmodium falciparum , 1984, Journal of bacteriology.

[51]  L. Sax,et al.  DRUG SENSITIVITY OF PLASMODIUM FALCIPARUM An In-vitro Microtechnique , 1978, The Lancet.

[52]  Loraine Ja.  World population situation during 1973. , 1974 .

[53]  K. Dietz,et al.  UvA-DARE ( Digital Academic Repository ) A thirteen-year analysis of Plasmodium falciparum populations reveals high conservation of the mutant pfcrt haplotype despite the withdrawal of chloroquine from national treatment guidelines in Gabon , 2017 .

[54]  P. Ringwald,et al.  Severe Malaria Not Responsive to Artemisinin Derivatives in Man Returning from Angola to Vietnam. , 2015, Emerging infectious diseases.

[55]  O. Aruoma,et al.  Cancer: Global Health Perspectives , 2014 .

[56]  David S Boyle,et al.  Emerging technologies for point-of-care CD4 T-lymphocyte counting. , 2012, Trends in biotechnology.

[57]  P. Kremsner,et al.  Is flow cytometry better in counting malaria pigment-containing leukocytes compared to microscopy? , 2009, Malaria Journal.

[58]  M. Wahlgren,et al.  METHODS IN MALARIA RESEARCH , 2008 .

[59]  R. Tsuyuoka,et al.  In vitro monitoring of Plasmodium falciparum susceptibility to artesunate, mefloquine, quinine and chloroquine in Cambodia: 2001-2002. , 2005, Acta tropica.

[60]  W. Wernsdorfer,et al.  In vitro response of chloroquine-resistant Plasmodium falciparum to mefloquine. , 1979, Bulletin of the World Health Organization.